Rising creatinine, proteinuria and a declining GFR are signs your kidneys need protection now. Our nephrology-guided program is designed to slow progression and protect kidney function — before dialysis becomes necessary.
Diabetic kidney disease often progresses silently through stages 1–4. Early detection of a falling eGFR and protein in the urine allows intervention that can meaningfully slow decline — long before symptoms appear.
Every kidney program at Boston Diabetes is reviewed by our U.S. nephrology advisor Dr. Barbara Ann Greco, MD (Harvard Medical School / UMass Chan — over 35 years in kidney care and transplantation). Meet our specialists guiding your care.
Structured renal-risk management can delay or prevent progression to end-stage disease. The earlier we intervene, the more kidney function we can preserve.
Every program follows the same three-stage pathway — comprehensive assessment, personalized intervention, and continuous outcome measurement.
eGFR staging, urine ACR, a full blood-pressure profile and a review of your current medications to establish where your kidneys stand.
Kidney-protective therapy with tailored blood-pressure and glucose targets, dietary guidance, and careful avoidance of nephrotoxic drugs.
Repeat eGFR and ACR tracking confirms that progression is slowing — so care stays guided by results, not assumptions.